source
- FDA advisory panel backs Moderna's experimental flu vaccine in adults 50-64, supports accelerated review for 65+The FDA's advisory committee voted unanimously to recommend Moderna's mRNA-1010 flu vaccine for adults aged 50 to 64, and also found it beneficial for those 65 and older. The 9-0 vote allows Moder…
- FDA vaccine advisors unanimously support Moderna's flu shotEvery member of a vaccine advisory panel for the FDA voted in favor of Moderna’s flu vaccine, after the product faced roadblocks from previous agency leadership. The Vaccines and Related Biological…Endpoints · 2mo ago↗ source